Consistent with the enhanced antitumor immune response and tumor growth inhibition attributed to STING and TBK1, we discovered that inhibiting CMA in a STING and TBK1-dependent manner enhanced antitumor immunity 20, 21. The gene discussed is STING1; the disease is neoplasm.